Human trial of new COVID 19 vaccine starts in UK
After this first phase, another trial is being planned for October, involving 6,000 people.
London: Volunteers have begun being immunised with a new UK coronavirus vaccine. About 300 people will have the vaccine over the coming weeks, as part of a trial led by Robin Shattock and his colleagues, at Imperial College London. Tests in animals suggest the vaccine is safe and triggers an effective immune response. Experts at Oxford University have already started human trials, the...
London: Volunteers have begun being immunised with a new UK coronavirus vaccine. About 300 people will have the vaccine over the coming weeks, as part of a trial led by Robin Shattock and his colleagues, at Imperial College London.
Tests in animals suggest the vaccine is safe and triggers an effective immune response.
Experts at Oxford University have already started human trials, the BBC reported on Wednesday.
The trials are among many across the world - there are around 120 vaccine programmes under way.
Read Also: Sanofi-GSK COVID-19 vaccine anticipates approval by early 2021
Kathy, 39, who works in finance, is one of the first volunteers taking part in the Imperial trial.
She said she volunteered because she wanted to play a part in fighting the virus.
"I think it came from not really knowing what I could do to help, and this turned out to be something that I could do.
"And understanding that it's not likely that things will get back to normal until there is a vaccine, so wanting to be part of that progress as well."
After this first phase, another trial is being planned for October, involving 6,000 people.
The Imperial team hopes the vaccine could be distributed in the UK and overseas from early 2021.
Meanwhile the Duke of Cambridge met volunteers taking part in Oxford University's trial, at the city's Churchill Hospital.
Prince William told the volunteers: "It's the most incredibly exciting and very welcome project that you're all doing which is why it's fascinating."
Many traditional vaccines are based on a weakened or modified form of virus, or parts of it, but the Imperial vaccine is based on a new approach, using synthetic strands of genetic code, called RNA, which mimic the virus.
Once injected into muscle, the RNA self-amplifies - generating copies of itself - and instructs the body's own cells to make copies of a spike protein found on the outside of the virus.
This should train the immune system to recognise and fight coronavirus without having to develop Covid-19.
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd